Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
5 years IF: 1.036 (® Thomson Reuters)
IF 2016: 1.064 (® Thomson Reuters)
Total Cites: 7140
Follow Us
Follow Us
  • Users Online: 2935
  • Home
  • Print this page
  • Email this page

    Article Cited by others

ORIGINAL ARTICLE

Expression of Total Vascular Endothelial Growth Factor and the Anti-angiogenic VEGF 165 b Isoform in the Vitreous of Patients with Retinopathy of Prematurity

Zhao Min, Xie Wan-Kun, Bai Yu-Jing, Huang Lyu-Zhen, Wang Bin, Liang Jian-Hong, Yin Hong, Li Xiao-Xin, Shi Xuan

Year : 2015| Volume: 128| Issue : 18 | Page no: 2505-2509

   This article has been cited by
 
1 SERUM LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR BEFORE AND AFTER INTRAVITREAL INJECTION OF RANIBIZUMAB OR CONBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Enzhong Jin,Yujing Bai,Ling Luo,Lvzhen Huang,Xuemei Zhu,Xue Ding,Huijun Qi,Mingwei Zhao
Retina. 2017; 37(5): 971
[Pubmed]  [Google Scholar] [DOI]
2 Risk of recurrence of retinopathy of prematurity after initial intravitreal ranibizumab therapy
Joyce J. T. Chan,Carol P. S. Lam,Madeline K. M. Kwok,Raymond L. M. Wong,Gary K. Y. Lee,Winnie W. Y. Lau,Jason C. S. Yam
Scientific Reports. 2016; 6: 27082
[Pubmed]  [Google Scholar] [DOI]

 

Read this article
京ICP备05052599号